Global Health Limited

Price Chart

Risk-Adjusted Performance

Global Health Limited (MEDANTA) Price Performance

Global Health Limited (MEDANTA) trades on NSE in INR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at INR973.80, down 3.17% from the previous close.

Over the past year, MEDANTA has traded between a low of INR973.80 and a high of INR1427.20. The stock has lost 26.6% over this period. It is currently 31.8% below its 52-week high.

Global Health Limited has a market capitalization of $292.37B, with a price-to-earnings ratio of 57.00.

About Global Health Limited

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.